FH ORTHO SAS Knee Observatory

NCT ID: NCT06207968

Last Updated: 2024-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

487 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-31

Study Completion Date

2044-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this observatory is to generate additional real life clinical data in accordance with local regulation (i.e. Post-Market Clinical Follow-up (PMCF) study, a study carried out following the European Conformity (CE) marking of a device and intended to answer specific questions relating to clinical safety or performance (i.e. residual risks) of a device when used in accordance with its approved instructions for use (IFU).

The difficulty of such an observatory is to be able to collect data on the different versions of the devices, on the different possible combinations of implants of an knee arthroplasty. The observatory must also be able to cover devices used in ligament reconstruction surgery.

The observatory will be based on the principle of a "dynamic" cohort during the inclusion period, i.e. with possible inclusions to replace the premature exits.

Technical solutions will be implemented to facilitate data collection from surgeons (electronic Case Report Form (eCRF) and from patients (Electronic Patient Reported Outcome (ePRO) on smartphone/tablet/computer) when feasible.

The data to be collected and the different follow-up times are based on our state-of-the-art, clinical evaluation plans and clinical evaluation reports.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PMCF as part of CE mark renewal, to answer questions related to the safety and clinical performance of the devices, when used according to their approved instructions for use.

This is an European, prospective and retrospective, multicenter, non-comparative study.

Randomization is considered impossible due to surgeon preference, anatomical conditions and other patient factors, and the use of different techniques.

This observatory is non-comparative, due to the absence of a gold standard and the technical, logistical and contractual constraints involved.

This PMCF study (CE-marked MD, any class, used as intended) provide additional non-burdensome and non-invasive procedures.

The Observatory will therefore be based on the principle of a "dynamic" cohort, i.e. with possible exits and inclusions throughout the Observatory period.

The aim of this methodology is to have a sufficient number of patients to be able to carry out descriptive statistical analyses each year, and to be able to calculate the evaluation criteria with the longest possible follow-up of results. Data will be collected before surgery, during surgery and at follow-up visits. Data collection will focus on obtaining short- and long-term data for performance and safety evaluation (up to 20 years for knee arthroplasty prostheses; up to 5 years for knee ligament reconstruction devices). In the case of knee arthroplasty, it is recommended to have performance and safety data at 1, 2, 5 and 10 years of follow-up, as well as safety data at 15 and 20 years if possible. In the case of ligament reconstruction, it is recommended to have performance and safety data at 1 and 2 years, as well as safety data at 5 years. The platform will be able to send automatic notifications to surgeons to remind them of scheduled patient follow-ups, missing data, and encourage them to include new patients if necessary. Self-questionnaires will be completed by patients via a web-based platform, available on computer or smartphone/tablet. Alternatively, patients will complete paper self-questionnaires, which will then be entered into the database by the investigating team.

It will also be possible to arrange for direct telephone contact with patients by an independent structure guaranteeing non-dissemination of nominative data (e.g. CRO). Telephone contact can also be made if the patient is geographically remote or has difficulty travelling. Patient recruitment: Continuous, consecutive, prospective and retrospective (for some implants because few implants have been used for this condition) recruitment to guarantee a minimum number of patients per type of device. Individual written information for each patient will be mandatory. A signed patient consent form will be required in Europe, after sufficient time for reflection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arthroplasty

Knee prostheses are intended for patients suffering from functionally serious diseases of the knee causing daily disability that is insufficiently improved by medical treatment.

The functional diseases are among:

* Knee osteoarthrosis
* Osteonecrosis of the knee
* Inflammatory disease
* Patellofemoral arthritis

The patients having benefited from an arthroplasty will be followed for at least 15 years (until 20 years).

Knee surgery with FH Ortho devices

Intervention Type DEVICE

This clinical investigation is a real-life observatory designed to collect long-term clinical data on patients who have undergone knee joint replacement or knee ligament reconstruction.

In this type of intervention, one or more medical devices distributed by FH ORTHO SAS may be used by surgeons.

Ligament reconstruction

Ligament reconstruction surgery should be considered for patient who have undergone a rupture of the anterior and/or posterior cruciate ligaments requiring partial or total reconstruction.

The patients having benefited from a ligament reconstruction will be followed for at least 5 years.

Knee surgery with FH Ortho devices

Intervention Type DEVICE

This clinical investigation is a real-life observatory designed to collect long-term clinical data on patients who have undergone knee joint replacement or knee ligament reconstruction.

In this type of intervention, one or more medical devices distributed by FH ORTHO SAS may be used by surgeons.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Knee surgery with FH Ortho devices

This clinical investigation is a real-life observatory designed to collect long-term clinical data on patients who have undergone knee joint replacement or knee ligament reconstruction.

In this type of intervention, one or more medical devices distributed by FH ORTHO SAS may be used by surgeons.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patient undergoing or having undergone implantation of medical devices distributed by FH ORTHO SAS for knee arthroplasty and ligament reconstruction, used in accordance with their approved IFU, in one of the centers participating in the Observatory.
* Patient is at least 18 years old at the time of surgery
* Patient agreeing to participate after having been informed orally and in writing (with written consent if required locally)
* In some countries, such as France, the patient will have to be socially insured to be included in the study.

Exclusion Criteria

For Arthroplasty:

1. Infection, or latent infection
2. A mental or neuromuscular disorder that might create an unacceptable risk of instability, prosthetic fixation failure, or complications after surgery
3. Insufficient bone stock for proper implant fixation
4. It is the surgeon's responsibility to make sure that the patient does not have any known allergies to one of the compounds of the material listed on the product label.
5. Metabolic diseases that might compromise bone regrowth
6. Drug addiction
7. Incomplete bone growth

For Ligament reconstruction:

1. Infection, or latent infection
2. A mental or neuromuscular disorder that might create an unacceptable risk of instability, prosthetic fixation failure, or complications after surgery
3. Insufficient bone stock
4. Known allergies to one of the compounds of the material listed on the product label.
5. Metabolic diseases that might compromise bone regrowth
6. Uncooperative patient unable to follow recommendations

As the medical devices are used in real life according to their indications, pregnant or breastfeeding women are not excluded from the study, but for safety reasons it is not advisable to include them in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

FH ORTHO

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Charles KAJETANEK, MD

Role: PRINCIPAL_INVESTIGATOR

Hôpitaux Privés Rennais - Saint-Grégoire (Vivalto Santé) Institut Locomoteur de l'Ouest

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique De La Chataigneraie

Beaumont, , France

Site Status

Clinique De La Miotte

Belfort, , France

Site Status

Polyclinique St Privat

Boujan-sur-Libron, , France

Site Status

Clinique Du Val D'Ouest

Écully, , France

Site Status

C.H. Raymond Poincare

Garches, , France

Site Status

Hôpital Saint Vincent de Paul

Lille, , France

Site Status

Hôpital Prive St Grégoire

Saint-Grégoire, , France

Site Status

Polyclinique De L'Europe

Saint-Nazaire, , France

Site Status

Medipole Garonne

Toulouse, , France

Site Status

Hôpital Privé Océane

Vannes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cindy Lai

Role: CONTACT

631315494 ext. +33

Stephanie Lhuillier

Role: CONTACT

607345965 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Charles CASIN, MD

Role: primary

Pierre Bastien REY, MD

Role: primary

Guillaume MIROUSE, MD

Role: primary

Benoit GIRAUD, MD

Role: primary

Jean-Claude BOU, MD

Role: primary

Charles Kajetanek, MD

Role: primary

Xavier CLÉMENT, MD

Role: primary

Rodolphe LIMOZIN, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exactech Knee Systems Post Market Clinical Follow-up
NCT07107581 ENROLLING_BY_INVITATION